---
title: "Todd Berg joins NeoChord as CEO"
date: "2024-02-23T10:50:54.000Z"
publishedDate: "23 février 2024"
summary: "NeoChord has appointed Todd Berg as chief executive officer to oversee clinical and commercial programmes for transeptal and transapical repair of damaged mitral valve chords resulting in regurgitation. Berg most recently served as CEO of Metavention, an intravascular denervation company which pioneered multi-organ denervation for the treatment of type 2 diabetes and hypertension."
importance: ""
sourceUrl: "https://cardiovascularnews.com/todd-berg-joins-neochord-as-ceo/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-02-23-todd-berg-joins-neochord-as-ceo"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/10/NeoChord.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/todd-berg-joins-neochord-as-ceo/"
---

![Todd Berg joins NeoChord as CEO](https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/10/NeoChord.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/todd-berg-joins-neochord-as-ceo/*

## L’essentiel

NeoChord has appointed Todd Berg as chief executive officer to oversee clinical and commercial programmes for transeptal and transapical repair of damaged mitral valve chords resulting in regurgitation. Berg most recently served as CEO of Metavention, an intravascular denervation company which pioneered multi-organ denervation for the treatment of type 2 diabetes and hypertension.

## Lien source

https://cardiovascularnews.com/todd-berg-joins-neochord-as-ceo/
